BD
0
Active Trials
0
Total Trials
0
Organizations
0
Events
Bangladesh
Medical Only (Private)
Reimbursed Care Access
Bangladesh maintains strict national controls on most classical psychedelics under the Narcotics Control Act (2018) and related scheduling; non‑medical possession, trafficking and importation are criminalized and actively policed by the Department of Narcotics Control (DNC). Ketamine is an established licensed anesthetic available in the commercial pharmaceutical market and used in clinical settings, but newer psychedelic medicines (e.g., psilocybin, MDMA, DMT family, ibogaine, mescaline, 2C‑X) have no authorised medical/marketing pathways and remain prohibited outside of research contexts.
No clinical trials found for this country yet.